Posts

Posted on

M1 @ $2.26

Sell @ $2.26

Another batch just became profitable at cost… Continue to reduce… But, still hope that a G.O. can materialise from China side… 😀

Posted on

RafflesMed @ $1.415

But @ $1.415

Finally got to buy back… Failed in Jump-Q for $1.41 due to last second sabotage… Q1 results flat, EPS a tiny but lower yoy… Cash growth is still ok… Likely need to wait till Q4 earliest for completion of hospital extension before we see any improvement in EPS… 😀

Posted on

SingTel @ $3.72

But @ $3.72

New addition to portfolio. Biz coming under attack soon by TPG in Singapore & Australia who’d won spectrum bids. Yield Rotation Play for 2H div (10.7ct for past 2 years), results expected in early May. 😀

Posted on

M1 @ $2.17

Sell @ $2.17

Contra off, can’t resist the temptation for a quick profit… 😀

Posted on

Portfolio – Q117

 

My portfolio (at cost) of S’pore stocks for Q117 close,

% Holding

Stocks

Total

> 5%

Frasers Com Tr

70.9%

  

Kep Infra Tr

  

  

Raffles Medical

  

  

M1

  

  

KingsmenCreative

  

  

King Wan

  

< 5%

SingPost

15.8%

  

F & N

  

  

Genting Sing

  

  

Starhub

  

Cash

  

13.4%

Note : Stocks are arranged in descending order of % holdings

 
Summary

The STI closed at 3175.11, +10.22% from end 2016. Using cost as a reference, my portfolio stats (vs 2016),

  • Size (Stocks Only) : +4.59% (Cost) / +8.25% (Market Value)
  • Portfolio Performance (Includes Cash) vs End-2016 Mkt Value : 1.68% (Unrealised) + 0.35% (Realised) + 0.49% (Div) = +2.52%
  • Further Breakdown of Realised P&L : +0.26% (Stocks Bought before 2017) + 0.09% (Stocks Bought in 2017)

So, +2.52% vs +10.22% (STI), a lot worse than STI!

For Q1, I have reduced my transaction volume considerably. I am fearful of the Trump-fuelled rally as it may be nothing but based purely only on optimism. As such, my focus is more on defense, rather than offense. This may be one of the reason for my gross under-performance. But, the main reason is buying too many wrong stocks!

For Q2, I plan to continue with my defensive approach and continue to sell into strength. My longer term hold counters continue to be KIT, FCOT and RafflesMed but I will also continue to trade a bit with my extras.

Portfolio Changes (vs Q416)

  • New Additions : —
  • Increases : FCOT, SingPost
  • Decreases : RafflesMed, M1
  • No Change : Kingsmen, King Wan, F&N, Genting, Starhub, KIT
  • No More : SGX, ARA

Exchange Rates (for Q117)

  • IDR (Indonesia Rupiah) -2.22% : LMIR – Weakened, perhaps due to religious protests during Jakarta Governor Election?
  • AUD (Australia $) +2.23% : AusNet, A-Htrust, Singtel, FLT – Continued to strengthen, missed buying A-HTrust & FLT at lower prices and pays Semi-Annual DPU for end-March Q
  • JPY (Japanese Yen) +0.49% : Strengthened a bit